Cannabis in Switzerland

Cannabis in Switzerland

Switzerland further benefits from a population with a high disposable income despite the Swiss economy being set to grow at a significantly below-average rate throughout 2023. Inflation is expected to be 2.3 % in 2023. The dampening effects of declining energy prices are offset by persistent price pressures in other areas. Supported by the good situation in the labour market, private consumption should nevertheless rise moderately throughout the year. High prices continue to weigh on household b...

Euromonitor International's Cannabis in Switzerland market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2028 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report??
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.